Related Experiment Video
Updated: Oct 7, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Pathomechanisms of Vascular Depression in Older Adults
1Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150 Vienna, Austria.
Insights
Late-life depression (LLD) is complex, with vascular and metabolic factors contributing significantly to its development and distinct characteristics. Understanding these factors is crucial for effective prevention and treatment strategies beyond standard antidepressants.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Vascular Biology
Background:
- Late-life depression (LLD) is a complex mood disorder in older adults, often co-occurring with physical illnesses and leading to disability and mortality.
- The precise risk factors for LLD remain unclear, and its underlying mechanisms differ from early-onset depression.
- The interplay between depression and age-related diseases suggests shared pathogenic pathways.
Purpose of the Study:
- To explore the contributing factors and pathogenic mechanisms of late-life depression (LLD).
- To discuss the "vascular depression" hypothesis and its implications.
- To highlight potential targets for LLD prevention and treatment.
Main Methods:
- Review of evidence linking vascular mechanisms (cerebral small vessel disease, endothelial dysfunction) and metabolic factors (diabetes, inflammation) to LLD.
- Discussion of the "vascular depression" hypothesis, emphasizing cerebrovascular disease and stroke.
- Consideration of neurodegenerative and neuroimmune factors in LLD pathogenesis.
Main Results:
- Vascular mechanisms, including cerebral small vessel disease and metabolic risk factors, are implicated in LLD development by causing brain lesions.
- The "vascular depression" hypothesis links cerebrovascular disease to geriatric depression, characterized by cognitive deficits and reduced white matter integrity.
- Vascular depression shows poorer response to antidepressants compared to major depressive disorder without vascular risk factors.
Conclusions:
- Vascular and metabolic factors are key contributors to LLD, influencing its presentation and treatment response.
- LLD may exhibit modest response to antidepressants, suggesting a need for targeted interventions.
- Vascular and metabolic pathways offer promising targets for LLD prevention and treatment, requiring further research and clinical validation.
Abstract:
Depression in older individuals is a common complex mood disorder with high comorbidity of both psychiatric and physical diseases, associated with high disability, cognitive decline, and increased mortality The factors predicting the risk of late-life depression (LLD) are incompletely understood. The reciprocal relationship of depressive disorder and age- and disease-related processes has generated pathogenic hypotheses and provided various treatment options. The heterogeneity of depression complicates research into the underlying pathogenic cascade, and factors involved in LLD considerably differ from those involved in early life depression. Evidence suggests that a variety of vascular mechanisms, in particular cerebral small vessel disease, generalized microvascular, and endothelial dysfunction, as well as metabolic risk factors, including diabetes, and inflammation that may induce subcortical white and gray matter lesions by compromising fronto-limbic and other important neuronal networks, may contribute to the development of LLD. The "vascular depression" hypothesis postulates that cerebrovascular disease or vascular risk factors can predispose, precipitate, and perpetuate geriatric depression syndromes, based on their comorbidity with cerebrovascular lesions and the frequent development of depression after stroke. Vascular burden is associated with cognitive deficits and a specific form of LLD, vascular depression, which is marked by decreased white matter integrity, executive dysfunction, functional disability, and poorer response to antidepressive therapy than major depressive disorder without vascular risk factors. Other pathogenic factors of LLD, such as neurodegeneration or neuroimmune regulatory dysmechanisms, are briefly discussed. Treatment planning should consider a modest response of LLD to antidepressants, while vascular and metabolic factors may provide promising targets for its successful prevention and treatment. However, their effectiveness needs further investigation, and intervention studies are needed to assess which interventions are appropriate and effective in clinical practice.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
The Effect of Aging on Tissues
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Drug Dosing: Geriatric Patients

